Century Therapeutics, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
EPS (Diluted)
$-0
Book Value Per Share
$2
Free Cash Flow Per Share
$-1
Cash Per Share
$1
Revenue Per Share
$1
OCF Per Share
$-1
Return on Equity
-6.0%
Return on Assets
-3.3%
Return on Invested Capital
-8.5%
Debt to Equity
—
Current Ratio
5.97
Quick Ratio
5.97
Asset Turnover
0.38
R&D / Revenue
87.6%
SBC / Revenue
6.3%
Capex / Revenue
0.8%
Working Capital
$101M
Net Current Asset Value
$56M
Invested Capital
$159M
OCF / Net Income
10.84
FCF / Net Income
10.93
Accruals Ratio (Sloan)
42.2%
Net Debt
$-117M
Net Debt / EBITDA
28.10
Interest Coverage
—
Cash Coverage
—
Capex Coverage
-122.50
Tangible Common Equity
$125M
TCE / Total Assets
55.8%
NOPAT
$-14M
Cash ROIC
-65.4%
WC / Revenue
92.1%
Capex / D&A
0.06
Reinvestment Rate
71.0%
Asset Growth vs Revenue Growth
-1593.4%
Stock Price (FY-end)
$1
Market Cap
$86M
P/S Ratio
0.79
P/B Ratio
0.54
P/TB Ratio
0.69
P/OCF Ratio
—
Enterprise Value
$-31M
EV / Sales
-0.28
FCF Yield
-121.6%
Shareholder Yield
-7.9%
R&D Yield
111.1%
Capex Yield
1.0%
Shares Variation (YoY)
10.1%
Beta (5Y)
1.31
Cost of Equity
11.0%
Cost of Debt (after tax)
—
52W High
$1
52W Low
$0
Trailing Return 1Y
-4.3%
F-Score (Piotroski)
3.00
Z-Score (Altman)
-3.39
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.